Hikma Pharmaceuticals PLC (HKMPF)
OTCMKTS · Delayed Price · Currency is USD
26.38
0.00 (0.00%)
At close: Jul 30, 2025
Bally's Market Cap
Hikma Pharmaceuticals has a market cap or net worth of $5.66 billion as of August 1, 2025. Its market cap has increased by 5.09% in one year.
Market Cap
5.66B
Enterprise Value
6.83B
Revenue
3.13B
Ranking
n/a
PE Ratio
15.77
Stock Price
$26.38
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 833.84M to 5.66B, an increase of 578.98%. That is a compound annual growth rate of 10.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 5.66B | 2.33% |
| Dec 31, 2024 | 5.53B | 9.82% |
| Dec 29, 2023 | 5.04B | 22.33% |
| Dec 30, 2022 | 4.12B | -40.78% |
| Dec 31, 2021 | 6.95B | -12.23% |
| Dec 31, 2020 | 7.92B | 24.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.76B |
| Veradigm | 794.80M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 546.09M |
| Glass House Brands | 409.73M |
| Nika Pharmaceuticals | 366.89M |
| CytoDyn | 357.98M |
| Northwest Biotherapeutics | 351.67M |